Dissociation of minor groove binders from DNA: insights from metadynamics simulations.
We have used metadynamics to investigate the mechanism of noncovalent dissociation from DNA by two representatives of alkylating and noncovalent minor groove (MG) binders. The compounds are anthramycin in its anhydrous form (IMI) and distamycin A (DST), which differ in mode of binding, size, flexibility and net charge. This choice enables to evaluate the influence of such factors on the mechanism of dissociation. Dissociation of IMI requires an activation free energy of approximately 12 kcal/mol and occurs via local widening of the MG and loss of contacts between the drug and one DNA strand, along with the insertion of waters in between. The detachment of DST occurs at a larger free energy cost, approximately 16.5 or approximately 18 kcal/mol depending on the binding mode. These values compare well with that of 16.6 kcal/mol extracted from stopped-flow experiments. In contrast to IMI, an intermediate is found in which the ligand is anchored to the DNA through its amidinium tail. From this conformation, binding and unbinding occur almost at the same rate. Comparison between DST and with kinetic models for the dissociation of Hoechst 33258 from DNA uncovers common characteristics across different classes of noncovalent MG ligands.
Vargiu
Attilio Vittorio
AV
CNR-INFM-SLACS and Department of Physics, University of Cagliari, I-09042 Cagliari, Italy.
Ruggerone
Paolo
P
Magistrato
Alessandra
A
Carloni
Paolo
P
D000477:Alkylating Agents / Q000737:chemistry*; D000876:Anthramycin / Q000737:chemistry*; D019295:Computational Biology; D003198:Computer Simulation; D004247:DNA / Q000737:chemistry*; D004214:Distamycins / Q000737:chemistry*; D008958:Models, Molecular; D009690:Nucleic Acid Conformation
D000477:Alkylating Agents; D004214:Distamycins; D000876:Anthramycin; C030000:stallimycin; D004247:DNA
J Am Chem Soc. 2006 Mar 1;128(8):2705-10
16492057
Methods Enzymol. 2001;340:212-33
11494850
Nucleic Acids Res. 1994 Jan 11;22(1):88-93
8127659
Chem Rev. 2011 Apr 13;111(4):2815-64
21166464
Curr Opin Struct Biol. 2008 Apr;18(2):185-93
18304803
J Phys Chem B. 2007 May 3;111(17):4553-9
17419610
J Am Chem Soc. 2006 Oct 18;128(41):13435-41
17031956
J Am Chem Soc. 2001 Jul 11;123(27):6485-95
11439034
J Comput Chem. 2005 Dec;26(16):1701-18
16211538
Arch Biochem Biophys. 2006 Sep 1;453(1):26-31
16730635
Phys Rev Lett. 2004 Apr 30;92(17):170601
15169135
Nat Prod Rep. 2001 Jun;18(3):291-309
11476483
Science. 1986 Apr 25;232(4749):464-71
2421408
J Comput Chem. 2004 Jul 15;25(9):1157-74
15116359
Mol Cell Biochem. 1997 Apr;169(1-2):61-72
9089632
Biophys J. 2004 Jul;87(1):58-64
15240444
Curr Opin Struct Biol. 1998 Jun;8(3):314-20
9666327
Biochemistry. 1993 Aug 24;32(33):8712-22
8357813
Biophys J. 2007 Feb 1;92(3):959-65
17114230
J Am Chem Soc. 2007 Nov 28;129(47):14739-45
17985896
Biochemistry. 2005 Dec 27;44(51):16988-97
16363812
Science. 1994 Feb 11;263(5148):777-84
8303294
Biochem Pharmacol. 1996 Aug 9;52(3):447-53
8687499
Nucleic Acids Res. 2005 Feb 01;33(2):725-33
15687382
J Chemother. 2007 Feb;19(1):66-78
17309854
Biochemistry. 2001 Jan 9;40(1):3-8
11141050
Biophys J. 2007 Jun 1;92(11):3817-29
17351000
Phys Rev A Gen Phys. 1985 Mar;31(3):1695-1697
9895674
J Comput Chem. 2005 May;26(7):725-37
15770662
J Mol Biol. 2001 May 11;308(4):649-63
11350167
Biophys J. 2008 Jan 15;94(2):550-61
18160662
J Biomol Struct Dyn. 1988 Aug;6(1):63-91
2482765
Biochemistry. 1986 Oct 7;25(20):5902-10
3790493
Proc Natl Acad Sci U S A. 1987 Dec;84(23):8385-9
3479798
Nat Rev Cancer. 2002 Mar;2(3):188-200
11990855
Arch Biochem Biophys. 2004 Sep 1;429(1):81-99
15288812
J Am Chem Soc. 2008 Jul 30;130(30):9747-55
18611009
J Comput Chem. 2004 Oct;25(13):1584-604
15264253
J Antibiot (Tokyo). 1977 May;30(5):349-70
328469
J Biomol Struct Dyn. 1999 Feb;16(4):845-62
10217454
J Phys Chem B. 2005 Apr 14;109(14):6676-87
16851750
J Am Chem Soc. 2005 Mar 2;127(8):2600-7
15725015
Pharm Res. 1984 Mar;1(2):52-9
24277212
J Mol Biol. 1987 Sep 20;197(2):257-71
2445998
Science. 2007 May 25;316(5828):1144-8
17525328
Br J Cancer. 2003 Oct 20;89(8):1559-65
14562032
J Phys Chem B. 2006 Dec 7;110(48):24687-95
17134232
Annu Rev Biophys Biomol Struct. 2005;34:153-71
15869387
Biophys J. 2003 Mar;84(3):1421-49
12609851
J Mol Biol. 2002 Feb 1;315(5):1049-61
11827475
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12562-6
12271136
J Mol Biol. 2002 Mar 29;317(3):361-74
11922670
J Am Chem Soc. 2004 Aug 11;126(31):9492-3
15291524
Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7814-8
10884413
Curr Opin Chem Biol. 1999 Dec;3(6):688-93
10600731
J Biomol Struct Dyn. 1989 Feb;6(4):669-99
2619934
Biochemistry. 1994 Nov 22;33(46):13593-610
7947769
Biophys J. 2006 Oct 15;91(8):2768-77
16877506
J Am Chem Soc. 2005 Jan 19;127(2):742-50
15643900
Prog Biophys Mol Biol. 1986;47(1):31-112
2422697
Proc Natl Acad Sci U S A. 1985 Mar;82(5):1376-80
2983343
J Biomol Struct Dyn. 1989 Feb;6(4):655-67
2619933
Bioorg Med Chem. 2001 Sep;9(9):2215-35
11553460
Med Res Rev. 2004 Jul;24(4):475-528
15170593
J Phys Chem B. 2005 Apr 14;109(14):6714-21
16851755
Biopolymers. 1997;44(3):201-15
9591476
J Mol Biol. 2004 Sep 3;342(1):73-89
15313608
Arch Biochem Biophys. 2002 Jul 1;403(1):1-15
12061796
J Phys Chem B. 2006 Mar 2;110(8):3647-60
16494420
Eur J Biochem. 2002 Jun;269(12):2868-77
12071949
Curr Med Chem. 2000 Jan;7(1):39-58
10637356
Biochemistry. 1994 Jul 26;33(29):8736-45
8038164
Angew Chem Int Ed Engl. 2006 Jun 19;45(25):4064-92
16761306
Eur J Cancer. 2007 Jan;43(2):308-15
17095209
Cancer Chemother Pharmacol. 2010 Jul;66(2):389-94
20480279
Acc Chem Res. 2006 Feb;39(2):73-81
16489726
Cancer Res. 2002 Apr 15;62(8):2332-6
11956092
Cancer Chemother Rep. 1962 May;18:15-9
13886432